Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2016:2016:8687575.
doi: 10.1155/2016/8687575. Epub 2016 Dec 26.

Basic Parameters of Blood Count as Prognostic Factors for Renal Cell Carcinoma

Grzegorz Prokopowicz  1 , Marcin Życzkowski  1 , Krzysztof Nowakowski  1 , Rafał Bogacki  1 , Piotr Bryniarski  1 , Andrzej Paradysz  1
Affiliations
Clinical Trial

Basic Parameters of Blood Count as Prognostic Factors for Renal Cell Carcinoma

Grzegorz Prokopowicz et al. Biomed Res Int. 2016.

Abstract

Background. Renal cell carcinoma is the most common type of kidney cancer. Taking account of morbidity and mortality increase, it is evident that searching for independent prognostic factors is needed. Aim of the Study. The aim of the study was to analyze routinely performed blood parameters as potential prognostic factors for kidney cancer. Material and Methods. We have retrospectively reviewed the records of 230 patients treated for renal cell carcinoma in the years 2000-2006. Preoperative blood parameters, postoperative histopathological results, and staging and grading were performed. To estimate the risk of tumor recurrence and cancer specific mortality (CSM) within five years of follow-up, uni- and multivariate Cox and regression analyses were used. To assess the quality of classifiers and to search for the optimal cut-off point, the ROC curve was used. Results. T stage of the tumor metastasis is the most important risk factor for early recurrence and cancer specific mortality (p < 0.001). The preoperative platelet count (PLT) above 351 × 103/uL (95.3%; 55.1%) and AUC of 77% are negative prognostic factors and correlate with increased cancer specific mortality (CSM) during the five-year follow-up (p < 0.001). Increased risk of local recurrence was observed for PLT above 243.5 × 103/ul (59%; 88%) and AUC of 80% (p = 0.001). The opposite was observed in the mean platelets volume (MPV) for cancer specific mortality (CSM). The cut-off point for the MPV was 10.1 fl (75.4%; 55.1%) and for the AUC is of 68.1% (p = 0.047). Conclusions. Many analyzed parameters in univariate regressions reached statistical significance and could be considered as potential prognostic factors for ccRCC. In multivariate analysis, only T stage, platelet count (PLT), and mean platelet volume (MPV) correlated with CSM or recurrent ccRCC.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests regarding the publication of this paper.

Figures

Figure 1
Figure 1
Anatomical location of the tumor according to the performed procedure.
Figure 2
Figure 2
Histological subtypes of RCC in the examined group.
Figure 3
Figure 3
Estimated recurrence-free survival according to the number of platelets.
Figure 4
Figure 4
Expected total survival relative to the mean platelet volume.
Figure 5
Figure 5
Upward sloping quality classifier of tumor recurrence versus platelet count.
Figure 6
Figure 6
Upward sloping classifier of death versus platelet count.
See this image and copyright information in PMC

References

    1. Butler B. P., Novick A. C., Miller D. P., Campbell S. A., Licht M. R. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology. 1995;45(1):34–40. doi: 10.1016/s0090-4295(95)96306-5. - DOI - PubMed
    1. McLaughlin J. K., Lipworth L. Epidemiologic aspects of renal cell cancer. Seminars in Oncology. 2000;27(2):115–123. - PubMed
    1. Lee J. H., You C. H., Min G. E., et al. Comparison of the surgical outcome and renal function between radical and nephron-sparing surgery for renal cell carcinomas. Korean Journal of Urology. 2007;48(7):671–676. doi: 10.4111/kju.2007.48.7.671. - DOI
    1. Borkowski A. Postępowanie diagnostyczne u chorych z guzami nerek oraz jego wpływ na sposób leczenia. Przewodnik Lekarza. 2001;10:92–95.
    1. Pascual D., Borque A. Epidemiology of kidney cancer. Advances in Urology. 2008;2008:7. doi: 10.1155/2008/782381.782381 - DOI - PMC - PubMed

Publication types

LinkOut - more resources